Thymosin-β4 Fragment 40-43

Healing & repair Research only Preliminary

Also called AGES

The last four amino acids of thymosin-β4. Researchers who mapped the parent peptide's activity tie this end to its anti-inflammatory effects. The source catalog gives no description for this item.

Evidence at a glance

Evidence: Preliminary — Very little published work
Status: Research compound only
Dosing: No human study has set a dose

Almost nothing published on this fragment by itself.

What studies report

Tied in mapping studies to the anti-inflammatory end of the parent peptide

How it works

The final four residues of thymosin-β4. Mapping studies associate this end with the anti-inflammatory activity, but it has barely been studied in isolation.

Binds a receptor on the cell surface and signals inward

Where it acts

Joints & cartilage

The library groups this compound under Healing & repair. The diagram shows that target, not every tissue it reaches.

Illustrated

A cell cutaway focused on a fine mesh of cytoskeletal actin filaments beneath the membrane.

AI-generated subject illustration; not a depiction of the compound or evidence of its effects.

Why people take it

Anti-inflammatory research

Reasons people seek it out — not a list of proven effects.

Status: Very little published data on the fragment by itself.

Route: Subcutaneous injection, from reconstituted lyophilised powder
Sequence: Ala-Gly-Glu-Ser
Available as: 5 mg

Search PubMed for Thymosin-β4 Fragment 40-43 → We link a live search rather than a fixed citation list, so it stays current and nothing here is a reference we have not checked.

Educational information only. Nothing here is medical advice, a dosing protocol, or a recommendation to use any compound. Most entries describe substances not approved for human use. Talk to a licensed clinician before acting on anything you read here. How to read these entries.